UBS sets a price target of $43 for BRKR, indicating an 11.08% potential increase.Bruker's third-quarter results show mid-single digit growth in organic bookings, suggesting a positive revenue trajectory.The Scientific Instruments segment's book-to-bill ratio exceeds 1.0, highlighting strong demand and future revenue potential.Bruker Corporation, listed on Nasdaq as BRKR, specializes in scientific instruments and solutions. The company serves various sectors, including academic and government institutions. B ...